MedTrace Logo

Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia

NCT04108364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-09-19

No results posted yet for this study

Summary

Rising life expectancy is leading to a rising incidence of strokes worldwide. Approximately one third of people who had a stroke live with a communication disorder, aphasia, which is associated with the largest negative relationship to quality of life. In chronic stages, people with aphasia (PwA) often do not receive any rehabilitation, despite treatment being shown to significantly reduce impairment. In contrast to existing computerized aphasia treatment, VoiceAdapt is an innovative and motivating application for PwA that provides adaptive and context-aware training lessons via speech interaction on the mobile device. A user-centred design process and motivational gamification ensure long-term engagement in training. Through providing an autonomously usable and low-cost tool, VoiceAdapt will positively affect PwA's self-esteem and social inclusion, leading to higher quality of life.

Conditions

  • Aphasia

Interventions

BEHAVIORAL

Voice adaptive training for aphasia

Training with the VoiceAdapt tablet-based therapy app 25 hours (1 hr/day x 5 days/week x 5 weeks)

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER

  • Technische Universität Berlin

    collaborator OTHER

  • AIT Austrian Institute of Technology GmbH

    collaborator OTHER

  • Nurogames GmbH

    collaborator UNKNOWN

  • University of Alberta

    lead OTHER

Principal Investigators

  • Esther S Kim, PhD · University of Alberta

  • Elizabeth Rochon, PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-09-30
Completion
2023-01-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108364 on ClinicalTrials.gov